Neurotoxicity of depleted uranium: Reasons for increased concern

Biological Trace Element Research

Volumn 110, Issue 1, 2006, Pages 1-17

  Jiang, George C T ^a   Aschner, Michael ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Depleted uranium; Gulf War syndrome; Neurotoxicity; Uranium

Indexed keywords

DNA; REACTIVE OXYGEN METABOLITE; URANIUM;

AIR POLLUTION; APOPTOSIS; ARMY; BONE CANCER; CENTRAL NERVOUS SYSTEM DISEASE; COMPARATIVE STUDY; EXPOSURE; FOOD CONTAMINATION; HEALTH HAZARD; HUMAN; INGESTION; KIDNEY DISEASE; LIPID BRAIN LEVEL; LIPID OXIDATION; LUNG CANCER; MASS SPECTROMETRY; NEUROTOXICITY; NONHUMAN; PERSIAN GULF SYNDROME; POPULATION EXPOSURE; PROTEOMICS; REPRODUCTIVE TOXICITY; REVIEW; SKIN INJURY; TRANSCRIPTOMICS; WATER CONTAMINATION;

HUMANS; NERVOUS SYSTEM; PERSIAN GULF SYNDROME; URANIUM;

EID: 33646880419     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:110:1:1     Document Type: Review

References (92)

1. N. H. Harley, E. C. Foulkes, L. H. Hilborne, A. Hudson, and C. R. Anthony, Depleted Uranium, RAND, Santa Monica, CA (1999).
2. 226,228Ra by New York City residents, Health Phys. 53, 357-563 (1987).
3. UNSCEAR - United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and Effects of Ionizing Radiation, Vol. I, United Nations, New York, p. 123 (2000).
4. UNSCEAR - United Nations Scientific Committee on the Effects of Atomic Radiation, Sources and Effects of Ionizing Radiation, Vol. II, United Nations, New York, p. 346 (2000).
5. Z. Pietrzak-Flis, L. Rosiak, M. M. Suplinska, E. Chrzanowski, and S. Dembinska, Daily intakes of 238U, 234U, 232Th, 230Th, 228Th and 226Ra in the adult population of central Poland, Sci. Total Environ. 273(1-3), 163-169 (2001).
6. H. Bem, and F. Bou-Rabee, Environmental and health consequences of depleted uranium use in the 1991 Gulf War, Environ. Int. 30, 123-134 (2004).
7. H. M. Hartmann, F. A. Monette, and I. H. Avci, Overview of toxicity data and risk assessment methods for evaluating the chemical effects of depleted uranium compounds, Hum. Ecol. Risk Assess. 6, 851-874 (2000).
8. M. D. Sztajnkrycer and E. J. Otten, Chemical and radiological toxicity of depleted uranium, Mil. Med. 169(3), 212-216 (2004).
9. WHO - Department of Protection of the Human Environment, Depleted Uranium: Sources, Exposure and Health Effects, WHO, Geneva.
10. R. F. Mould, Depleted uranium and radiation-induced lung cancer and leukaemia, Br. J. Radiol. 74, 677-683 (2001).
11. I. M. Fisenne, P. M. Perry, and N. H. Harley, Uranium in humans, Rad. Prot. Dosim. 24, 127-131 (1988).
12. US DoD (Department of Defense), Depleted uranium in the Gulf. Environmental exposure report. Available from http://www.deploymentlink.osd.mil/ du_library/du_ii/.
13. M. A. McDiarmid, J. P. Keogh, F. J. Hooper, et al., Health effects of depleted uranium on exposed Gulf War veterans, Environ. Res. 82, 168-180 (2000).
14. M. A. McDiarmid, Depleted uranium and public health, Br. Med. J. 322, 123-124, (2001).
15. M. A. McDiarmid, S. M. Engelhardt, and M. Oliver, Urinary uranium concentrations in an enlarged Gulf War veteran cohort, Health Phys. 80(3), 270-273 (2001).
16. M. A. McDiarmid, K. Squibb, S. Engelhardt, et al., Surveillance of depleted uranium exposed Gulf War veterans: health effects observed in an enlarged "friendly-fire" cohort, J. Occup. Envron. Med. 43, 991-1000 (2001).
17. M. A. McDiarmid, K. Squibb, and S. M. Engelhardt, Biologic monitoring for urinary uranium in Gulf War I veterans, Health Phys. 87(1), 51-56 (2004a).
18. H. S. Spencer, D. Osis, I. M. Fisenne, P. Perry, and N. H. Harley, Measured intake and excretion patterns of naturally occurring 238U and calcium in humans, Radiat. Res. 24, 90-95 (1990).
19. R. H. Gwiazda, K. Squibb, M. McDiarmid, and D. Smith, Detection of depleted uranium in urine of veterans from the 1991 Gulf War, Health Phys. 86(1), 12-18 (2004).
20. R. E. J. Mitchel and S. Sunder, Depleted uranium dust from fired munitions: physical, chemical and biological properties, Health Phys. 87(1), 57-67 (2004).
21. P. R. Danesi, A. Bleise, W. Burkart, et al., Isotopic composition and origin of uranium and plutonium in selected soil samples collected in Kosovo, J. Environ. Radioact. 64(2-3), 121-131 (2003).
22. L. A. Di Lella, L. Frati, S. Loppi, G. Protano, and F. Riccobono, Environmental distribution of uranium and other trace elements at selected Kosovo sites, Chemosphere 56(9), 861-865 (2004).
23. L. A. Di Lella, F. Nannoni, G. Protano, and F. Riccobono, Uranium contents and (235)U/(238)U atom ratios in soil and earthworms in western Kosovo after the 1999 war, Sci. Total Environ. 337(1-3), 109-118 (2005).
24. B. Salbu, K. Janssens, O. C. Lind, K. Proost, L. Gijsels, and P. R. Danesi, Oxidation states of uranium in depleted uranium particles from Kuwait, J. Environ. Radioact. 78(2), 125-135 (2005).
25. S. Ihrulj, A. Krunic-Haveric, S. Haveric, N. Pojskic, and R. Hadziselimovic, Micronuclei occurrence in population exposed to depleted uranium and control human group in correlation with sex, age and smoking habit, Med. Arh. 58(6), 335-338 (2004).
26. M. A. McDiarmid, S. Engelhardt, M. Oliver, et al., Surveillance of depleted uranium exposed Gulf War veterans: a 10-year follow-up, J. Toxicol. Envron. Health 67, 277-296 (2004).
27. M. A. McDiarmid, F. J. Hooper, K. Squibb, et al., Health effects and biological monitoring results of Gulf War veterans exposed to depleted uranium, Mil Med. 167(2 Suppl.), 123-124 (2002).
28. H. C. Hodge, Handbook of Experimental Pharmacology: Uranium, Plutonium, Transplutonic Elements, H. C. Hodge, J. N. Stannard, and J. B. Hursh, eds., Springer-Verlag, New York, pp. 5-68 (1973).
29. D. R. Goodman, Nephrotoxicity: toxic effects in the kidneys, in Industrial Toxicology and Health Applications in the Workplace, P. L. Wilson and J. L. Bur[???]son, eds., Van Nostrand Reinhold, New York (1995).
30. M. Carrière, L. Avoscan, R. Collins, et al., Influence of uranium speciation on normal rat kidney (NRK-52E) proximal cell cytotoxicity, Chem. Res. Toxicol. 17, 446-452 (2004).
31. B. L'Azou, M. H. Henge-Napoli, L. Minaro, H. Mirto, M. P. Barrouillet, and J. Cambar, Effects of cadmium and uranium on some in vitro renal targets, Cell. Biol. Toxicol. 18, 329-340 (2002).
32. A. C. Miller, A. F. Fuciarelli, W. E. Jackson, et al., Urinuary and serum mutagenicity studies with rats implanted with depleted uranium or tantalum pellets, Mutagenesis 13(6), 643-648 (1998).
33. A. C. Miller, W. F. Blakely, D. Livengood, et al., Transformation of human osteoblast cells to the tumorigenic phenotype by depleted uranium-uranyl chloride, Environ. Health Perspect. 106(8), 465-471 (1998).
34. A. C. Miller, K. Brooks, M. Stewart, et al., Genomic instability in human osteoblast cells after exposure to depleted uranium: delayed lethality and micronuclei formation, J. Environ. Radioact. 64(2-3), 247-259 (2003).
35. A. Durakovic, On depleted uranium: Gulf War and Balkan Syndrome, Croat. Med. J. 42(2), 130-134 (2001).
36. A. Durakovic, P. Horan, L. A. Dietz, and I. Zimmerman, Estimate of the time zero lung burden of depleted uranium in Persian Gulf War veterans by the 24-hour urinary excretion and exponential decay analysis, Mil. Med. 168(8), 600-605 (2003).
37. M. A. Kadhim, D. A. Macdonald, D. T. Goodhead, S. A. Lorimore, S. J. Marsden, and E. G. Wright, Transmission of chromosomal instability after plutonium alpha-particle irradiation, Nature 355(6362), 738-740 (1992).
38. M. A. Kadhim, S. A. Lorimore, M. D. Hepburn, D. T. Goodhead, V. J. Buckle, and E. G. Wright, Alpha-particle-induced chromosomal instability in human bone marrow cells, Lancet 344(8928), 987-988 (1994).
39. H. Schroder, A. Heimers, R. Frentzel-Beyme, A. Schott, and W. Hoffmann, Chromosome aberration analysis in peripheral lymphocytes of Gulf War and Balkans War veterans, Radiat. Prot. Dosim. 103(3), 211-219 (2003).
40. H. Nagasawa and J. B. Little, Induction of sister chromatid exchanges by extremely low doses of alpha-particles, Cancer Res. 52(22), 6394-6396 (1992).
41. A. C. Miller, S. Mog, L. McKinney, et al., Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects, Carcinogenesis 22(1), 115-125 (2001).
42. A. C. Miller, J. Xu, M. Stewart, et al., Observation of radiation-specific damage in human cells exposed to depleted uranium: dicentric frequency and neoplastic transformation as endpoints, Radiat. Prot. Dosim. 99(1-4), 275-278 (2002).
43. A. C. Miller, K. Brooks, J. Smith, and N. Page, Effect of the militarily-relevant heavy metals, depleted uranium and heavy metal tungsten-alloy on gene expression in human liver carcinoma cells (HepG2), Mol. Cell Biochem. 255, 247-256 (2004).
44. B. E. Lehnert, E. H. Goodwin, and A. Deshpande, Extracellular factor(s) following exposure to alpha particles can cause sister chromatid exchanges in normal human cells, Cancer Res. 57(11), 2164-2171; erratum 63(6), 1439 (1997).
45. C. H. Kennedy, C. E. Mitchell, N. H. Fukushima, R. E. Neft, and J. F. Lechner, Induction of genomic instability in normal human bronchial epithelial cells by 238Pu alpha-particles, Carcinogenesis 17(8), 1671-1676 (1996).
46. R. H. Lin, L. J. Wu, C. H. Lee, and S. Y. Kin-Shiau, Cytogenetic toxicity of uranyl nitrate in Chinese hamster ovary cells, Mutat. Res. 319, 197-203 (1993).
47. F. F. Hahn, R. A. Guilmette, and M. D. Hoover, Implanted depleted uranium fragments cause soft tissue sarcomas in the muscles of rats, Environ. Health Perspect. 110(1), 51-59 (2002).
48. C. Voegtlin, and H. C. Hodge, eds., Pharmacology and Toxicology of Uranium Compounds. Part 1. McGraw-Hill, New York (1949).
49. C. Voegtlin and H. C. Hodge, eds., Pharmacology and Toxicology of Uranium Compounds Part 2. McGraw-Hill, New York (1949).
50. L. J. Leach, E. A. Maynard, H. C. Hodge, et al., A five-year inhalation study with natural uranium dioxide (UO 2) dust. I. Retention and biologic effect in the monkey, dog and rat, Health Phys. 18(6), 599-612 (1970).
51. 2) dust. II. Postexposure retention and biologic effects in the monkey, dog and rat, Health Phys. 25(3), 239-258 (1973).
52. 4, Int. J. Radiat. Biol. 75(3), 373-377 (1999).
53. C. Voegtlin and H. C. Hodge, eds., Pharmacology and Toxicology of Uranium Compounds. Part 3. McGraw-Hill, New York (1953).
54. C. Voegtlin and H. C. Hodge, eds., Pharmacology and Toxicology of Uranium Compounds. Part 4. McGraw-Hill, New York (1953).
55. N. D. Priest, Toxicity of depleted uranium, Lancet 357, 244-246 (2001).
56. J. L. Domingo, Reproductive and developmental toxicity of natural and depleted uranium: a review, Reprod. Toxicol. 14, 603-609 (2001).
57. D. P. Arfsten, K. R. Still, and G. D. Ritchie, A review of the effects of uranium and depleted uranium exposure on reproduction and fetal development, Toxicol. Ind. Health. 17(5-10), 180-191 (2001).
58. A. W. Abu-Qare and M. B. Abou-Donia, Depleted uranium - the growing concern, J. Appl. Toxicol. 22(3), 149-152 (2002).
59. T. C. Pellmar, A. F. Fuciarelli, J. W. Ejnik, et al., Distribution of uranium in rats implanted with depleted uranium pellets, Toxicol. Sci. 49, 29-39 (1999).
60. T. C. Pellmar, D. O. Keyser, C. Emery, and J. B. Hogan, Electrophysiological changes in hippocampal slices isolated from rats embedded with depleted uranium fragments, Neurotoxicology 20(5), 785-792 (1999).
61. W. Briner and J. Murray, Effects of short-term and long-term depleted uranium exposure on open-field behavior and brain lipid oxidation in rats, Neurotoxicol. Teratol. 27(1), 135-144 (2005).
62. D. S. Barber, M. F. Ehrich, and B. S. Jortner, The effect of stress on the temporal and regional distribution of uranium in rat brain after acute uranyl acetate exposure, J. Toxicol. Environ. Health A 68(2), 99-111 (2005).
63. R. H. Lin, W. M. Fu, and S. Y. Lin-Shiau, Presynaptic action of uranyl nitrate on the phrenic nerve-diaphragm preparation of the mouse, Neuropharmacology 27(8), 857-863 (1988).
64. A. P. Gilman, D. C. Villeneuve, V. E. Secours, et al., Uranyl nitrate: 28-day and 91-day toxicity studies in the Sprague-Dawley rat, Toxicol. Sci. 41(1), 117-128 (1998).
65. A. P. Gilman, D. C. Villeneuve, V. E. Secours, et al., Uranyl nitrate: 91-day toxicity studies in the New Zealand white rabbit, Toxicol. Sci. 41(1), 129-137 (1998).
66. A. P. Gilman, M. A. Moss, D. C. Villeneuve, et al., Uranyl nitrate: 91-day exposure and recovery studies in the male New Zealand white rabbit, Toxicol. Sci. 41(1), 138-151 (1998).
67. V. Lemercier, X. Millot, E. Ansoborlo, et al., Study of uranium transfer across the blood-brain barrier. Radiat. Prot. Dosim. 105(1-4), 243-245 (2003).
68. M. B. Abou-Donia, A. M. Dechkovskaia, L. B. Goldstein, D. U. Shah, S. L. Bullman, and W. A. Khan, Uranyl acetate-induced sensorimotor deficit and increased nitric oxide generation in the central nervous system in rats, Pharmacol. Biochem. Behav. 72, 881-890 (2002).
69. US Department of Defense, Population representation in the military services, fiscal year 2000. Available from http://www.dod.mil/prhome/poprep2000/ html/chapter8/c8_actgender.htm (2000).
70. F. J. Hooper, K. S. Squibb, E. L. Siegel, K. McPhaul, and J. P. Keogh, Elevated urine uranium excretion by soldiers with retained uranium shrapnel, Health Phys. 77(5), 512-519 (1999).
71. International Commission on Radiological Protection, Report of the Task Groups on Reference Man. 23, Pergamon Elmsford, NY (1974).
72. A. Durakovic, Undiagnosed illnesses and radioactive warfare, Croat. Med. J. 44(5), 520-532 (2003).
73. US DoD (Department of Defense), Depleted uranium in the Gulf. Environmental exposure report. Available from http://www.gulflink.osd.mil/du (1998).
74. US DoD (Department of Defense), Depleted uranium in the Gulf. Environmental exposure report. Available from http://www.deploymentlink.osd.mil/ du_library/du_ii/. (2000).
75. The Royal Society, The Health Effects of Depleted Uranium Munitions. Part I. The Royal Society, London (2001).
76. The Royal Society, The Health Effects of Depleted Uranium Munitions. Part II. The Royal Society, London (2002).
77. The Royal Society, The Health Effects of Depleted Uranium Munitions. Summary. Document 6/62, The Royal Society, London (2002).
78. E. Weir, Uranium in drinking water, naturally, C. M. A. J. 170(6), 951-952 (2004).
79. A. C. Miller, M. Stewart, K. Brooks, L. Shi, and N. Page, Depleted uranium-catalyzed oxidative DNA damage: absence of significant alpha particle decay, J. Inorg. Biochem. 91, 246-252 (2002).
80. M. Yazzie, S. L. Gamble, E. R. Civitello, and D. M. Stearns, Uranyl acetate causes DNA single-strand breaks in vitro in the presence of ascorbate (vitamin C), Chem. Res. Toxicol. 16(4), 524-530 (2003).
81. M. Taulan, F. Paquet, C. Maubert, O. Delissen, J. Demaille, and M. C. Romey, Renal toxicogenomic response to chronic uranyl nitrate insult in mice, Environ. Health Perspect. 112(16), 1628-1635 (2004).
82. O. Prat, F. Berenguer, V. Malard, et al., Transcriptomic and proteomic responses of human renal HEK293 cells to uranium toxicity, Proteomics 5(1), 297-306 (2005).
83. R. Furuya, H. Kumagai, and A. Hishida, Acquired resistance to rechallenge injury with uranyl acetate in LLC-PK1 cells, J. Lab. Clin. Med. 129(3), 347-355 (1997).
84. S. Mizuno, K. Fujita, R.Furuy et al., Association of HSP73 with the acquired resistance to uranyl acetate-induced acute renal failure, Toxicology 117(2-3), 183-191 (1997).
85. J. K. Tolson, S. M. Roberts, B. Jortner, M. Pomeroy, and D. S. Barber, Heat shock proteins and acquired resistance to uranium nephrotoxicity, Toxicology 206(1), 59-73 (2005).
86. J. F. Kalinich, N. Ramakrishnan, V. Villa, and D. E. McClain, Depleted uranium-uranyl chloride induces apoptosis in mouse J774 macrophages, Toxicology 79, 105-114 (2002).
87. D. Fahey, Science or science fiction? Facts, myths, and propaganda in the debate over depleted uranium weapons. Available from http://www.antenna.nl/ wise/uranium/pdf/dumyths.pdf. (2003)
88. S. Milacic, D. Petrovic, D. Jovicic, R. Kovacevic, and J. Simic, Examination of the health status of populations from depleted-uranium- contaminated regions, Environ. Res. 95(1), 2-10 (2004).
89. N. Obralic, F. Gavrankapetanovic, Z. Dizdarevic, et al., The number of malignant neoplasm in Sarajevo region during the period 1998-2002, Med. Arh. 58(5), 275-278 (2004).
90. Z. Karpas, L. Halicz, J. Roiz, et al., Inductively coupled plasma mass spectrometry as a simple, rapid, and inexpensive method for determination of uranium in urine and fresh water: comparison with LIF. Health Phys. 71(6), 879-885 (1996).
91. J. W. Ejnik, A. J. Carmichael, M. M. Hamilton, et al., Determination of the isotopic composition of uranium in urine by inductively coupled plasma mass spectrometry, Health Phys. 78(2), 143-146 (2000).
92. A. Ortega, J. L. Domingo, J. M. Llobet, J. M. Tomas, and J. L. Paternain. Evaluation of the oral toxicity of uranium in a 4-week drinking-water study in rats, Bull. Environ. Contam. Toxicol. 42(6), 935-941.